Marcelino Ford-Livene and Dr. Cathy A. Petti elected to the Corus International Board of Directors

  • John Rivera
  • Mar 24, 2021

WASHINGTON AND BALTIMORE — Marcelino Ford-Livene, an executive with Intel Capital, and Dr. Cathy A. Petti, founder and CEO of MoDx, a medical knowledge domain platform, have been elected to the Corus International board of directors.

Ford-Livene and Petti will serve three-year terms on the Corus board.

Ford-Livene is managing director at Intel Capital, the corporate venture capital arm of Intel Corporation. He manages assets in Intel Capital’s global portfolio of companies and leads a team that delivers strategic business, marketing, operations and technical support to technology companies receiving venture capital funding from Intel. He also provides leadership to Intel Capital’s diversity and inclusion initiative outreach efforts, investments and company-building activities.

Previously, he was the general manager of Intel’s Worldwide Corporate Affairs Group. In this role, he led an international organization across 30 countries tasked with developing and executing strategies, policies and programs that advanced Intel’s global brand and long-standing commitment to corporate responsibility and social impact. He also held senior positions with the Federal Communications Commission, including special counsel for new media policy.

Ford-Livene serves on the board of IRIS.TV, a leading video data technology company. He is also a founding director of the Digital Diversity Network and a volunteer mentor in the L.A.M.P. Mentor Program, which promotes leadership, community service and decision-making skills for high school students.

Petti is a health technology executive and the founder and CEO of MoDx, a medical knowledge domain platform integrating diagnostics, digital health and artificial intelligence. She has served in a number of senior executive roles at the intersection of medicine and technology, and continues to practice as an infectious diseases physician. As the global head at Novartis Diagnostics, she was responsible for expanding global markets for their core products and building R&D teams for three de novo franchises. As chief health officer at Ancestry, Petti built its direct-to-consumer health genetic testing portfolio. She led ARUP Infectious Diseases Laboratory, one of the country’s largest infectious diseases laboratories, where she pioneered research in DNA sequencing.

Petti shares her expertise and leadership with several global non-profit organizations and regulatory agencies, including having chaired committees for the Clinical and Laboratory Standards Institute, as well as serving as program lead for Infectious Diseases Society of America and advising the FDA Microbiology Device Committee.

Previously, Petti was a governor appointee and member of the Board of Directors for Utah’s Science, Technology and Research (USTAR) Initiative. Committed to underserved populations, she received the College of American Pathologists’ Humanitarian Award for her work in providing diagnostic testing in sub-Saharan Africa, was awarded the 2015 ASMIUSSTF Indo-US Professorship in Microbiology and served as 2019 Visiting Professor to the Infectious Diseases Institute in Kampala, Uganda.


# # #

Corus International is the parent of a family of long-serving organizations committed to ending poverty and building healthy communities in the world’s most challenging places. Drawing on a heritage of nearly 150 years, Corus connects and catalyzes non-profit and for-profit subsidiaries that include Lutheran World Relief, IMA World Health, CGA Technologies, Ground Up Investing and Farmers Market Brands LLC. Alongside communities in fragile settings, their dedicated experts integrate disciplines, approaches and people to grow local economies, eliminate extreme poverty, ensure access to quality health care, mitigate climate change and respond to humanitarian crises.